These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29558108)

  • 1. Effects of Nanoprobe Morphology on Cellular Binding and Inflammatory Responses: Hyaluronan-Conjugated Magnetic Nanoworms for Magnetic Resonance Imaging of Atherosclerotic Plaques.
    Hossaini Nasr S; Tonson A; El-Dakdouki MH; Zhu DC; Agnew D; Wiseman R; Qian C; Huang X
    ACS Appl Mater Interfaces; 2018 Apr; 10(14):11495-11507. PubMed ID: 29558108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging.
    El-Dakdouki MH; El-Boubbou K; Kamat M; Huang R; Abela GS; Kiupel M; Zhu DC; Huang X
    Pharm Res; 2014 Jun; 31(6):1426-37. PubMed ID: 23568520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.
    Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X
    Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
    Chan JM; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Gibbs RG
    Eur J Vasc Endovasc Surg; 2014 May; 47(5):462-9. PubMed ID: 24594295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.
    Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ
    J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice.
    von Elverfeldt D; von zur Muhlen C; Wiens K; Neudorfer I; Zirlik A; Meissner M; Tilly P; Charles AL; Bode C; Peter K; Fabre JE
    PLoS One; 2012; 7(9):e45008. PubMed ID: 23028736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring Zinc Ferrite Nanoparticle Surface Coating for Macrophage-Affinity Magnetic Resonance Imaging of Atherosclerosis.
    Wen L; Fu X; Zhang H; Ye P; Fu H; Zhou Z; Sun R; Xu T; Fu C; Zhu C; Guo Y; Fan H
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13496-13508. PubMed ID: 38449094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis.
    Ma Q; Wu S; Yang L; Wei Y; He C; Wang W; Zhao Y; Wang Z; Yang S; Shi D; Liu Y; Zhou Z; Sun J; Zhou Y
    Adv Sci (Weinh); 2023 Feb; 10(5):e2202416. PubMed ID: 36529695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
    Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
    Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging.
    Uca YO; Hallmann D; Hesse B; Seim C; Stolzenburg N; Pietsch H; Schnorr J; Taupitz M
    Mol Imaging Biol; 2021 Jun; 23(3):382-393. PubMed ID: 33289060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic Acid-Functionalized Gadolinium Doped Iron Oxide Nanoparticles for Atherosclerosis-Targeted Mr Imaging.
    Yu M; Niu Y; Zhou D; Jiang R; Zhang L; Ju H; Gong A; Zou S; Zhang M; Du F
    J Biomed Nanotechnol; 2019 Jan; 15(1):127-137. PubMed ID: 30480520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
    Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.
    Zhu Y; Fang Y; Wang Y; Han D; Liu J; Tian L; Xu M; Wang Y; Cao F
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1530-1543. PubMed ID: 38372216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid nanoparticles for active targeting atherosclerosis.
    Lee GY; Kim JH; Choi KY; Yoon HY; Kim K; Kwon IC; Choi K; Lee BH; Park JH; Kim IS
    Biomaterials; 2015; 53():341-8. PubMed ID: 25890732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
    Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
    Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
    Scharlach C; Kratz H; Wiekhorst F; Warmuth C; Schnorr J; Genter G; Ebert M; Mueller S; Schellenberger E
    Nanomedicine; 2015 Jul; 11(5):1085-95. PubMed ID: 25659644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.